Abstract | OBJECTIVE: METHODS: We evaluated the effectiveness of early introduction of low-dose amitriptyline combined with abrupt withdrawal in outpatients with MOH over a 1-year observational period. The primary outcome measures were the reduction in number of headache days and days with use of acute headache medication after 3 months and after 12 months. A number of secondary outcome measures, as well as safety and tolerability, were assessed. The responders were defined as patients with ≥50% reduction in headache frequency from baseline and being without medication overuse. RESULTS: Thirty-three patients completed the study. Significant reductions in headache frequency and medication consumption were observed at both months 3 and 12, compared to baseline (P < 0.05 for all). Neither the primary nor the secondary endpoints differed significantly between months 3 and 12. At the 12-month follow-up, 58% of the patients were considered as responders (N = 19); 73% remained cured of MOH (N = 24); 64% had reverted to episodic headaches (N = 21); 27% had relapsed into MOH (N = 9). CONCLUSION: Given these results, early introduction of low-dose amitriptyline combined with abrupt withdrawal could be considered as a choice for patients with MOH.
|
Authors | Wen Fan, Yuhua Lv, Guomin Ying, Wangwen Li, Jiying Zhou |
Journal | Pain medicine (Malden, Mass.)
(Pain Med)
Vol. 15
Issue 10
Pg. 1803-10
(Oct 2014)
ISSN: 1526-4637 [Electronic] England |
PMID | 25159678
(Publication Type: Clinical Trial, Journal Article, Observational Study)
|
Copyright | Wiley Periodicals, Inc. |
Chemical References |
- Analgesics, Non-Narcotic
- Amitriptyline
|
Topics |
- Adult
- Aged
- Amitriptyline
(therapeutic use)
- Analgesics, Non-Narcotic
(therapeutic use)
- Female
- Follow-Up Studies
- Headache Disorders, Secondary
(drug therapy)
- Humans
- Male
- Middle Aged
- Pilot Projects
- Treatment Outcome
|